Publications by authors named "Michiko Hanawa"

Claim this Profile
E
Efficacy and safety of a novel pain management device, AT-04, for endometriosis-related pain: study protocol for a phase III randomized controlled trial.
Hiroshi Ishikawa, Osamu Yoshino, Fuminori Taniguchi, Tasuku Harada, Mikio Momoeda, Michiko Hanawa

Reprod Health· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.
Noriyuki Okonogi, Kazutoshi Murata, Shigeru Yamada, Yuji Habu, Makoto Hori, Michiko Hanawa

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, multicenter, single-arm study to assess the utility of indocyanine green fluorescent lymphography in the treatment of secondary lymphedema.
Shinsuke Akita, Naoki Unno, Jiro Maegawa, Yoshihiro Kimata, Hidekazu Fukamizu, Michiko Hanawa

J Vasc Surg Venous Lymphat Disord· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
Noriyuki Okonogi, Hirokazu Usui, Kazutoshi Murata, Makoto Hori, Tomoya Kurokawa, Michiko Hanawa

BMJ Open· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Propranolol Gel for Infantile Hemangioma: A Randomized, Double-Blind Study.
Naoaki Rikihisa, Hirokazu Takatsuka, Takaaki Suzuki, Yuki Shiko, Yohei Kawasaki, Michiko Hanawa

Biol Pharm Bull· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of granulocyte colony-stimulating factor for spinal cord injury.
Masao Koda, Hideki Hanaoka, Yasuhisa Fujii, Michiko Hanawa, Yohei Kawasaki

Brain· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Naoki Hosogaya, Taiga Miyazaki, Yuri Fukushige, Sachiko Takemori, Shinpei Morimoto, Michiko Hanawa

Trials· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury.
Masao Koda, Hideki Hanaoka, Takatoshi Sato, Yasuhisa Fujii, Michiko Hanawa

BMJ Open· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis